• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GCNCPR-ACPs:一种用于预测 ACPs 的新型图卷积网络方法。

GCNCPR-ACPs: a novel graph convolution network method for ACPs prediction.

机构信息

School of Informatics, Xiamen University, Xiamen, Fujian, China.

Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.

出版信息

BMC Bioinformatics. 2022 Dec 23;23(Suppl 4):560. doi: 10.1186/s12859-022-04771-2.

DOI:10.1186/s12859-022-04771-2
PMID:36564705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9789540/
Abstract

BACKGROUND

Anticancer peptide (ACP) inhibits and kills tumor cells. Research on ACP is of great significance for the development of new drugs, and the prediction of ACPs and non-ACPs is the new hotspot.

RESULTS

We propose a new machine learning-based method named GCNCPR-ACPs (a Graph Convolutional Neural Network Method based on collapse pooling and residual network to predict the ACPs), which automatically and accurately predicts ACPs using residual graph convolution networks, differentiable graph pooling, and features extracted using peptide sequence information extraction. The GCNCPR-ACPs method can effectively capture different levels of node attributes for amino acid node representation learning, GCNCPR-ACPs uses node2vec and one-hot embedding methods to extract initial amino acid features for ACP prediction.

CONCLUSIONS

Experimental results of ten-fold cross-validation and independent validation based on different metrics showed that GCNCPR-ACPs significantly outperformed state-of-the-art methods. Specifically, the evaluation indicators of Matthews Correlation Coefficient (MCC) and AUC of our predicator were 69.5% and 90%, respectively, which were 4.3% and 2% higher than those of the other predictors, respectively, in ten-fold cross-validation. And in the independent test, the scores of MCC and SP were 69.6% and 93.9%, respectively, which were 37.6% and 5.5% higher than those of the other predictors, respectively. The overall results showed that the GCNCPR-ACPs method proposed in the current paper can effectively predict ACPs.

摘要

背景

抗癌肽(ACP)能抑制和杀伤肿瘤细胞。ACP 的研究对于新药的开发具有重要意义,而 ACP 和非 ACP 的预测是新的热点。

结果

我们提出了一种新的基于机器学习的方法,命名为 GCNCPR-ACPs(基于坍塌池化和残差网络的图卷积神经网络方法来预测 ACP),该方法使用残差图卷积网络、可区分图池化和使用肽序列信息提取的特征,自动且准确地预测 ACP。GCNCPR-ACPs 方法可以有效地捕获节点属性的不同层次,用于氨基酸节点表示学习,GCNCPR-ACPs 使用 node2vec 和 one-hot 嵌入方法提取初始氨基酸特征进行 ACP 预测。

结论

基于不同指标的十折交叉验证和独立验证的实验结果表明,GCNCPR-ACPs 显著优于最先进的方法。具体来说,我们的预测器的马修斯相关系数(MCC)和 AUC 的评估指标分别为 69.5%和 90%,分别比十折交叉验证中其他预测器高 4.3%和 2%。在独立测试中,MCC 和 SP 的得分分别为 69.6%和 93.9%,分别比其他预测器高 37.6%和 5.5%。总体结果表明,本文提出的 GCNCPR-ACPs 方法可以有效地预测 ACP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/eb6b3c33db3d/12859_2022_4771_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/2664fc17c64d/12859_2022_4771_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/ace92fb77f5f/12859_2022_4771_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/317885bdfe39/12859_2022_4771_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/eb6b3c33db3d/12859_2022_4771_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/2664fc17c64d/12859_2022_4771_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/ace92fb77f5f/12859_2022_4771_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/317885bdfe39/12859_2022_4771_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63f/9789540/eb6b3c33db3d/12859_2022_4771_Fig4_HTML.jpg

相似文献

1
GCNCPR-ACPs: a novel graph convolution network method for ACPs prediction.GCNCPR-ACPs:一种用于预测 ACPs 的新型图卷积网络方法。
BMC Bioinformatics. 2022 Dec 23;23(Suppl 4):560. doi: 10.1186/s12859-022-04771-2.
2
mACPpred 2.0: Stacked Deep Learning for Anticancer Peptide Prediction with Integrated Spatial and Probabilistic Feature Representations.mACPpred 2.0:具有集成空间和概率特征表示的用于抗癌肽预测的堆叠深度学习。
J Mol Biol. 2024 Sep 1;436(17):168687. doi: 10.1016/j.jmb.2024.168687. Epub 2024 Jun 25.
3
CAPTURE: Comprehensive anti-cancer peptide predictor with a unique amino acid sequence encoder.CAPTURE:具有独特氨基酸序列编码器的综合抗癌肽预测器。
Comput Biol Med. 2024 Jun;176:108538. doi: 10.1016/j.compbiomed.2024.108538. Epub 2024 May 3.
4
GCNGAT: Drug-disease association prediction based on graph convolution neural network and graph attention network.GCNGAT:基于图卷积神经网络和图注意力网络的药物-疾病关联预测。
Artif Intell Med. 2024 Apr;150:102805. doi: 10.1016/j.artmed.2024.102805. Epub 2024 Feb 17.
5
ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation.ACP-DA:利用数据增强改进抗癌肽的预测
Front Genet. 2021 Jun 30;12:698477. doi: 10.3389/fgene.2021.698477. eCollection 2021.
6
Prediction of Membrane Protein Amphiphilic Helix Based on Horizontal Visibility Graph and Graph Convolution Network.基于水平可见性图和图卷积网络的膜蛋白两亲性螺旋预测。
IEEE/ACM Trans Comput Biol Bioinform. 2023 Nov-Dec;20(6):3567-3574. doi: 10.1109/TCBB.2023.3305493. Epub 2023 Dec 25.
7
DLFF-ACP: prediction of ACPs based on deep learning and multi-view features fusion.DLFF-ACP:基于深度学习和多视图特征融合的急性冠脉综合征预测
PeerJ. 2021 Aug 3;9:e11906. doi: 10.7717/peerj.11906. eCollection 2021.
8
ME-ACP: Multi-view neural networks with ensemble model for identification of anticancer peptides.ME-ACP:用于识别抗癌肽的具有集成模型的多视图神经网络。
Comput Biol Med. 2022 Jun;145:105459. doi: 10.1016/j.compbiomed.2022.105459. Epub 2022 Mar 26.
9
MDTL-ACP: Anticancer Peptides Prediction Based on Multi-Domain Transfer Learning.MDTL-ACP:基于多域迁移学习的抗癌肽预测
IEEE J Biomed Health Inform. 2025 Mar;29(3):1714-1725. doi: 10.1109/JBHI.2023.3347138. Epub 2025 Mar 6.
10
Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning.基于深度学习的癌症治疗肽类药物预测
Pharmaceuticals (Basel). 2022 Mar 30;15(4):422. doi: 10.3390/ph15040422.

本文引用的文献

1
Recent advances in network-based methods for disease gene prediction.基于网络的疾病基因预测方法的最新进展。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa303.
2
Predicting human microbe-drug associations via graph convolutional network with conditional random field.基于条件随机场的图卷积网络预测人体微生物-药物关联
Bioinformatics. 2020 Dec 8;36(19):4918-4927. doi: 10.1093/bioinformatics/btaa598.
3
Dual-dropout graph convolutional network for predicting synthetic lethality in human cancers.双失活图卷积网络预测人类癌症中的合成致死性。
Bioinformatics. 2020 Aug 15;36(16):4458-4465. doi: 10.1093/bioinformatics/btaa211.
4
ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides.ACPred-Fuse:融合多视图信息可改善抗癌肽的预测。
Brief Bioinform. 2020 Sep 25;21(5):1846-1855. doi: 10.1093/bib/bbz088.
5
PEPred-Suite: improved and robust prediction of therapeutic peptides using adaptive feature representation learning.PEPred-Suite:使用自适应特征表示学习提高和优化治疗性肽的预测。
Bioinformatics. 2019 Nov 1;35(21):4272-4280. doi: 10.1093/bioinformatics/btz246.
6
Empirical comparison and analysis of web-based cell-penetrating peptide prediction tools.基于网络的细胞穿透肽预测工具的实证比较和分析。
Brief Bioinform. 2020 Mar 23;21(2):408-420. doi: 10.1093/bib/bby124.
7
Comparative analysis and prediction of quorum-sensing peptides using feature representation learning and machine learning algorithms.使用特征表示学习和机器学习算法对群体感应肽进行比较分析和预测。
Brief Bioinform. 2020 Jan 17;21(1):106-119. doi: 10.1093/bib/bby107.
8
ACPred-FL: a sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides.ACPred-FL:一种基于序列的预测器,使用有效的特征表示来提高抗癌肽的预测能力。
Bioinformatics. 2018 Dec 1;34(23):4007-4016. doi: 10.1093/bioinformatics/bty451.
9
MLACP: machine-learning-based prediction of anticancer peptides.MLACP:基于机器学习的抗癌肽预测
Oncotarget. 2017 Aug 19;8(44):77121-77136. doi: 10.18632/oncotarget.20365. eCollection 2017 Sep 29.
10
iACP-GAEnsC: Evolutionary genetic algorithm based ensemble classification of anticancer peptides by utilizing hybrid feature space.iACP - GAEnsC:基于进化遗传算法的利用混合特征空间对抗癌肽进行集成分类
Artif Intell Med. 2017 Jun;79:62-70. doi: 10.1016/j.artmed.2017.06.008. Epub 2017 Jun 17.